EA200601247A1 - Новые многократно замещённые соединения 1,1-пиридиламиноциклопропанамина, способ их получения и фармацевтические композиции, которые их содержат - Google Patents

Новые многократно замещённые соединения 1,1-пиридиламиноциклопропанамина, способ их получения и фармацевтические композиции, которые их содержат

Info

Publication number
EA200601247A1
EA200601247A1 EA200601247A EA200601247A EA200601247A1 EA 200601247 A1 EA200601247 A1 EA 200601247A1 EA 200601247 A EA200601247 A EA 200601247A EA 200601247 A EA200601247 A EA 200601247A EA 200601247 A1 EA200601247 A1 EA 200601247A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cyclopropanamine
pyridylamino
contain
production
pharmaceutical compositions
Prior art date
Application number
EA200601247A
Other languages
English (en)
Other versions
EA011124B1 (ru
Inventor
Соло Голдстейн
Клод Гиллонно
Ив Шарто
Брайан Локхарт
Пьер Лестаж
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200601247A1 publication Critical patent/EA200601247A1/ru
Publication of EA011124B1 publication Critical patent/EA011124B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Соединения формулы (I)в которой n представляет собой целое число от 1 до 6 включительно, Rи Rпредставляют собой атом водорода, C-С-алкильную группу или арил-С-С-алкильную группу, Rи Rпредставляют собой атом водорода или C-С-алкильную группу, Rи Rпредставляют собой атом водорода или C-С-алкил, галоген, гидрокси, C-С-алкокси, циано, нитро, С-С-ацил, C-С-алкоксикарбонил, C-С-тригалоалкил или C-С-тригалоалкокси группу или необязательно замещенную аминогруппу, Rпредставляет собой атом водорода, C-С-алкильную группу или арилалкильную группу. Лекарственные средства.
EA200601247A 2005-07-28 2006-07-27 Новые многократно замещённые соединения 1,1-пиридиламиноциклопропанамина, способ их получения и фармацевтические композиции, которые их содержат EA011124B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508032A FR2889188B1 (fr) 2005-07-28 2005-07-28 Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
EA200601247A1 true EA200601247A1 (ru) 2007-04-27
EA011124B1 EA011124B1 (ru) 2008-12-30

Family

ID=36169157

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601247A EA011124B1 (ru) 2005-07-28 2006-07-27 Новые многократно замещённые соединения 1,1-пиридиламиноциклопропанамина, способ их получения и фармацевтические композиции, которые их содержат

Country Status (32)

Country Link
US (2) US7388022B2 (ru)
EP (1) EP1757586B1 (ru)
JP (1) JP2007031439A (ru)
KR (1) KR100824831B1 (ru)
CN (1) CN100448848C (ru)
AR (1) AR055589A1 (ru)
AT (1) ATE416166T1 (ru)
AU (1) AU2006203237A1 (ru)
BR (1) BRPI0603027A (ru)
CA (1) CA2552831A1 (ru)
CR (1) CR9679A (ru)
DE (1) DE602006003956D1 (ru)
DK (1) DK1757586T3 (ru)
EA (1) EA011124B1 (ru)
EC (1) ECSP088127A (ru)
ES (1) ES2318700T3 (ru)
FR (1) FR2889188B1 (ru)
GE (1) GEP20084506B (ru)
GT (1) GT200800005A (ru)
HK (1) HK1098146A1 (ru)
HR (1) HRP20090090T3 (ru)
MA (1) MA28425B1 (ru)
MX (1) MXPA06008541A (ru)
NO (1) NO20063462L (ru)
NZ (1) NZ548746A (ru)
PL (1) PL1757586T3 (ru)
PT (1) PT1757586E (ru)
SG (1) SG129412A1 (ru)
SI (1) SI1757586T1 (ru)
TN (1) TNSN08023A1 (ru)
WO (1) WO2007012761A1 (ru)
ZA (1) ZA200606276B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2896800B1 (fr) * 2006-01-30 2008-04-11 Servier Lab Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US10288289B2 (en) * 2014-12-12 2019-05-14 United Technologies Corporation Gas turbine engine diffuser-combustor assembly inner casing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2095350C1 (ru) * 1993-10-13 1997-11-10 Центр по химии лекарственных средств (ЦХЛС-ВНИХФИ) 3-(n,n-диметилкарбамоилокси)-2-этил-6-метилпиридина сукцинат, обладающий антигипоксической активностью
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
EE04588B1 (et) * 1997-10-27 2006-02-15 Neurosearch A/S Heteroarüüldiasatsükloalkaanid kui atsetüülkoliini nikotiinretseptorite kolinergilised ligandid, nende kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
CA2376061A1 (en) * 1999-06-07 2000-12-14 Targacept, Inc. Pharmaceutical compositions and methods for use
JP2001261652A (ja) * 2000-03-21 2001-09-26 Suntory Ltd 二置換イミノヘテロサイクリック化合物
US6448276B1 (en) * 2000-05-17 2002-09-10 Inspire Pharmaceuticals, Inc. Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists
FR2810664B1 (fr) * 2000-06-27 2004-12-24 Adir Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AR055589A1 (es) 2007-08-29
DK1757586T3 (da) 2009-03-09
US20080146621A1 (en) 2008-06-19
SI1757586T1 (sl) 2009-04-30
US7388022B2 (en) 2008-06-17
EP1757586B1 (fr) 2008-12-03
ECSP088127A (es) 2008-02-20
FR2889188A1 (fr) 2007-02-02
EA011124B1 (ru) 2008-12-30
HRP20090090T3 (en) 2009-03-31
US20070027192A1 (en) 2007-02-01
CN1903844A (zh) 2007-01-31
WO2007012761A8 (fr) 2007-12-21
ZA200606276B (en) 2007-12-27
BRPI0603027A (pt) 2007-03-13
AU2006203237A1 (en) 2007-02-15
KR100824831B1 (ko) 2008-04-23
ES2318700T3 (es) 2009-05-01
NZ548746A (en) 2007-06-29
JP2007031439A (ja) 2007-02-08
TNSN08023A1 (en) 2009-07-14
ATE416166T1 (de) 2008-12-15
CR9679A (es) 2008-02-20
CA2552831A1 (fr) 2007-01-28
MXPA06008541A (es) 2007-01-29
CN100448848C (zh) 2009-01-07
DE602006003956D1 (en) 2009-01-15
NO20063462L (no) 2007-01-29
PT1757586E (pt) 2009-02-17
HK1098146A1 (en) 2007-07-13
WO2007012761A1 (fr) 2007-02-01
GT200800005A (es) 2008-09-24
KR20070015012A (ko) 2007-02-01
MA28425B1 (fr) 2007-02-01
FR2889188B1 (fr) 2007-09-07
GEP20084506B (en) 2008-10-10
EP1757586A1 (fr) 2007-02-28
PL1757586T3 (pl) 2009-04-30
SG129412A1 (en) 2007-02-26

Similar Documents

Publication Publication Date Title
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
EA200970156A1 (ru) Пиридизиноновые производные
SE0301373D0 (sv) Novel compounds
UY29360A1 (es) Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones.
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
CY1112495T1 (el) Κυτταροτοξικοι παραγοντες που περιλαμβανουν νεα παραγωγα τομαϋμυκινης
HRP20070076A2 (en) Pyrimidine derivatives
TW200616979A (en) Non-nucleoside reverse transcriptase inhibitors
CY1110034T1 (el) Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
EA201101334A1 (ru) Новые соединения бензотиадиазепина, способ их приготовления и фармацевтические композиции, содержащие их
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
ATE449069T1 (de) Aminopropanolderivate
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE482933T1 (de) Sulfopyrrolderivate
TW200624429A (en) Novel cysteine protease inhibitors
EA200801681A1 (ru) Новые многократно замещенные соединения пиридиниламиноалкилен- и пиридинилоксиалкиленциклопропанамина, способ их получения и фармацевтические композиции, которые их содержат
DK1819704T3 (da) Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU